189
Views
3
CrossRef citations to date
0
Altmetric
Research Articles

Perfluorooctane sulfonate (PFOS) triggers migration and invasion of esophageal squamous cell carcinoma cells via regulation of Zeb1

, , , , &
Pages 2804-2813 | Received 23 Jul 2021, Accepted 02 Oct 2021, Published online: 03 Nov 2021
 

Abstract

Esophageal squamous cell carcinoma (ESCC) is one of the most prevalent and deadly cancers worldwide, especially in Eastern Asia. As a potential endocrine-disrupting chemical (EDC), perfluorooctane sulfonate (PFOS) can mimic estrogen, disturb the estrogen signals, and then cause various diseases. Although ESCC can be directly exposed to PFOS during food digestion, the effects and mechanisms of PFOS on the development of ESCC are still not well illustrated. This study showed that PFOS can promote the migration and invasion of ESCC cells. Further, PFOS treatment can increase the expression of matrix metalloproteinase-2 (MMP-2) and MMP-9, while decreasing the expression of E-Cadherin (E-Cad). Zeb1, an important transcription factor for cell motility, was essential for PFOS induced migration and invasion of ESCC cells. PFOS can increase the expression of Zeb1 via upregulation of its transcription and proteins stability. A-kinase interacting protein 1 (AKIP1) and ataxia-telangiectasia mutated (ATM) were responsible for PFOS induced transcription and proteins stability of Zeb1 in ESCC cells, respectively. Collectively, our data indicated that environmental exposure and body accumulation of PFOS might be an important risk factor for ESCC progression.

Ethical approval

No animal or human-related experiment. All authors give the consent for the publishing of this study.

Author contributions

Conception and design: Yaqing Liu, Jian Li, Hui Ding, Chunjin Xu;

Acquisition of data: Yaqing Liu, Dahe Ge, Juntao Wang, Chunjin Xu;

Analysis and interpretation of data: Hui Ding, Dahe Ge, Juntao Wang, Chunjin Xu;

Writing, review, and/or revision of the manuscript: Yaqing Liu, Jian Li, Chunjin Xu.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Data availability statement

All data and material are available.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.